House Of Pathology Labs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-11-2024
- Paid Up Capital ₹ 2.50 M
as on 08-11-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 169.14%
(FY 2023)
- Profit -197.49%
(FY 2023)
- Ebitda -778.85%
(FY 2023)
- Net Worth -148.52%
(FY 2023)
- Total Assets 31.95%
(FY 2023)
About House Of Pathology Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Balkishan Saini, Rajeev Arora, Deepa Gandhi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300HR2021PTC096992
- Company No.
096992
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2021
- Date of AGM
25 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at House Of Pathology Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balkishan Saini  | Director | 13-Aug-2021 | Current |
| Rajeev Arora | Additional Director | 13-Sep-2021 | Current |
| Deepa Gandhi | Director | 13-Aug-2021 | Current |
| Manzar Alam | Director | 13-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of House Of Pathology Labs.
House Of Pathology Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 169.14% increase. The company also saw a substantial fall in profitability, with a 197.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 148.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of House Of Pathology Labs?
Unlock access to House Of Pathology Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at House Of Pathology Labs?
House Of Pathology Labs has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of House Of Pathology Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped House Of Pathology Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
